Bangladesh vs Belize: Estimated antiretroviral therapy coverage among people living with HIV
Bangladesh
44.0%
in 2025
Belize
47.0%
in 2025
Bangladesh rank
131st
Belize rank
129th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Bangladesh
- Belize
How they compare
Belize currently reports 47.0% against 44.0% in Bangladesh, a difference of 3.0%.
That makes Belize's figure about 1.1 times Bangladesh's.
Across all 26 years both countries report, Belize has been ahead every year.
Bangladesh ranks 131st and Belize ranks 129th of 143 countries.
Belize has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | Belize | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.4% | 10.7% | 9.3% | Belize |
| 2010s | 15.1% | 29.8% | 14.7% | Belize |
| 2020s | 35.7% | 41.8% | 6.2% | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Bangladesh or Belize?
- Belize, at 47.0% against 44.0% in Bangladesh as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Bangladesh and Belize?
- 3.0%, with Belize ahead.
- How many years of comparable data are there for Bangladesh and Belize?
- 26 years are reported by both, from 2000 to 2025.
- How do Bangladesh and Belize rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Bangladesh ranks 131st and Belize ranks 129th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.